09/03/2025
12:09 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2025
3:13 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
6:29 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/11/2025
6:14 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2025
4:56 PM | Immunovant (Issuer)
Venker Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2025
4:10 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2025
4:11 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2025
3:02 PM | Immunovant (Subject)
Macias William L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025
4:34 PM | Immunovant (Subject)
Macias William L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025
4:42 PM | Immunovant (Subject)
Macias William L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2025
6:14 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
05/29/2025
6:30 AM | Immunovant (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
05/21/2025
3:24 PM | Immunovant (Subject)
MIGAUSKY GEORGE V (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
6:30 PM | Immunovant (Issuer)
Susman Robert Graham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
6:30 PM | Bauer Jake (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
6:30 PM | Girao Tiago (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
4:01 PM | Immunovant (Issuer)
Susman Robert Graham (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/28/2025
4:02 PM | Bauer Jake (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/28/2025
4:03 PM | Girao Tiago (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/21/2025
6:18 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2025
6:54 AM | Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
04/17/2025
3:07 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2025
3:08 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
3:05 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:50 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:51 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:53 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:55 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:41 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:43 PM | Hughes Douglas J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:44 PM | Immunovant (Issuer)
Pande Atul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:46 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:48 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:37 PM | Immunovant (Issuer)
Torti Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
6:51 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
3:18 PM | Fromkin Andrew J. (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:17 PM | Fromkin Andrew J. (Reporting)
Immunovant (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
9:01 AM | FMR LLC (Filed by)
Immunovant (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
5:45 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
5:37 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:20 PM | Immunovant (Filer)
| Form 424B3 | |
|
01/24/2025
4:24 PM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:22 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2025
3:23 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
4:16 PM | Immunovant (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/15/2025
3:36 PM | Immunovant (Issuer)
Roivant Sciences Ltd. (Reporting)
Roivant Sciences Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2025
3:30 PM | Immunovant (Subject)
Roivant Sciences Ltd. (Filed by)
Roivant Sciences Ltd. (Filed by)
| Form SCHEDULE 13D/A | |
01/14/2025
7:09 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:07 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:01 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2024
4:02 PM | Immunovant (Issuer)
Van Tuyl Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:11 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:12 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:09 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
3:08 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
4:11 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2024
4:15 PM | Gloria Melanie (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
5:42 AM | Immunovant (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
5:49 AM | Immunovant (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
3:21 PM | Immunovant (Issuer)
Stout Jay S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:23 PM | Geffner Michael (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:25 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:27 PM | Barnett Eva Renee (Reporting)
Immunovant (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:28 PM | Immunovant (Issuer)
Levine Mark S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:30 PM | Immunovant (Issuer)
Macias William L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:31 PM | Immunovant (Issuer)
Salzmann Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
